Page last updated: 2024-11-05

trihexyphenidyl and Akinetic Autism

trihexyphenidyl has been researched along with Akinetic Autism in 2 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research Excerpts

ExcerptRelevanceReference
"A case of akinetic mutism was reported with reference to a marked improvement by levodopa, bromocriptine and trihexyphenidyl."1.27[Akinetic mutism from recurrent hydrocephalus: successful treatment with levodopa, bromocriptine and trihexyphenidyl]. ( Kurahashi, K; Matsunaga, M; Narita, S; Tanaka, T; Watahiki, Y, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaijima, M1
Fukuda, H1
Tomabechi, M1
Hodozuka, A1
Watahiki, Y1
Narita, S1
Kurahashi, K1
Tanaka, T1
Matsunaga, M1

Other Studies

2 other studies available for trihexyphenidyl and Akinetic Autism

ArticleYear
[Effect of trihexyphenidyl-HCL on posttraumatic prolonged disturbance of consciousness: report of two cases].
    No shinkei geka. Neurological surgery, 1989, Volume: 17, Issue:5

    Topics: Aged; Akinetic Mutism; Craniocerebral Trauma; Humans; Magnetic Resonance Imaging; Male; Middle Aged;

1989
[Akinetic mutism from recurrent hydrocephalus: successful treatment with levodopa, bromocriptine and trihexyphenidyl].
    No to shinkei = Brain and nerve, 1987, Volume: 39, Issue:10

    Topics: Adult; Akinetic Mutism; Bromocriptine; Drug Therapy, Combination; Humans; Hydrocephalus; Levodopa; M

1987